Quadrant Capital Group’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4K Buy
1,099
+981
+831% +$17.1K ﹤0.01% 2042
2025
Q4
$2.1K Buy
118
+93
+372% +$1.63K ﹤0.01% 2515
2025
Q3
$464 Buy
+25
New +$515 ﹤0.01% 2624
2025
Q1
Sell
-103
Closed -$2.39K 2805
2024
Q4
$2.39K Sell
103
-525
-84% -$13.1K ﹤0.01% 2472
2024
Q3
$17K Sell
628
-68
-10% -$2.06K ﹤0.01% 1968
2024
Q2
$20K Sell
696
-30
-4% -$920 ﹤0.01% 1853
2024
Q1
$21.2K Hold
726
﹤0.01% 1826
2023
Q4
$23.6K Buy
726
+694
+2,169% +$20.1K ﹤0.01% 1740
2023
Q3
$1.02K Buy
+32
New +$1.23K ﹤0.01% 2485
2020
Q3
Sell
-999
Closed -$44K 2240
2020
Q2
$44K Buy
+999
New +$44.9K 0.01% 765

Other funds holding KIDS

Quadrant Capital Group's KIDS Position: Q1 2026 in Review

Quadrant Capital Group increased its OrthoPediatrics (KIDS) stake by 831% in Q1 2026, buying an estimated $17.1K and bringing the position to 1,099 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Quadrant Capital Group first reported a position in KIDS in Q2 2020 and has held it in 10 quarters since. The position peaked at $44K in Q2 2020. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Quadrant Capital Group held 1,099 shares of OrthoPediatrics worth $17.4K as of Q1 2026.
  • Quadrant Capital Group bought 981 OrthoPediatrics shares in Q1 2026, an estimated $17.1K.
  • OrthoPediatrics made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2042 holding.
  • Quadrant Capital Group first reported a position in OrthoPediatrics in Q2 2020 and has held it in 10 quarters since.
  • Quadrant Capital Group's OrthoPediatrics position peaked at $44K in Q2 2020.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.